| iQone Healthcare Switzerland SA - Remsima 350 mg, solution à diluer pour perfusion |
| 70236 | | 02 | | Remsima 350 mg | | solution à diluer pour perfusion | | L04AB02 | | Infliximab | | 06.07.2026 | | |
|
| Composition |
| infliximabum 350 mg, acidum aceticum, natrii acetas trihydricus corresp. natrium max. 2.20 mg, sorbitolum 393.8 mg, polysorbatum 80 4.4 mg, aqua ad iniectabile ad solutionem pro 8.75 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Infliximab | 350mg / 8.75ml |
| | BAG: Active Agent |
|---|
| Infliximab |
| | | | Inactive agents | Dose |
|---|
| Acetic Acid | | | Natrii Acetas Trihydricus | | | Polysorbatum 80 | 4.4mg / 8.75ml | | Sorbitol | 393.8mg / 8.75ml |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | | 1735.34 | 1903.70 | A | SL | No |
|